JOHNSON & JOHNSON
LIVE

Serial Number

98179225

Owner

Johnson & Johnson

Attorney

David McDonald

Filing Date

Sep 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

JOHNSON & JOHNSON Trademark

Serial Number: 98179225

JOHNSON & JOHNSON is a trademark filed by Johnson & Johnson on September 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Johnson & Johnson (5 trademarks)

Skillman, NJ 08558

Entity Type: 03

Trademark Details

Filing Date

September 14, 2023

Registration Date

Not Registered

Published for Opposition

August 27, 2024

Goods & Services

Scientific research for medical and healthcare purposes; research and development services in the fields of drug discovery, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting clinical trials for others; scientific research consulting; providing scientific information in the field of laboratory technology; medical laboratory services; medical and pharmacological research services; providing online non-downloadable computer software for accessing information related to all aspects of health, personal care, nutrition, wellness, and the development and use of pharmaceuticals, medicaments and medical products

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; orthopedic articles, namely, shoulder, hip, knee, spine, foot and ankle prostheses; suture materials; surgical robots and surgical robotic instruments; surgical visualization systems comprised primarily of medical imaging apparatus for use in surgical procedures and also incorporating computer hardware and display monitors for video processing and image management during surgical procedures

Pharmaceutical and medicinal preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers; chemical, biochemical and biological preparations and agents for medical purposes, namely for use in orthopedic surgeries; diagnostic preparations for medical use; medical dressings; hemostatic agents for surgical use; drug delivery agents in the form of compounds, capsules, powders, dissolvable films, or liquids that facilitate the delivery of a wide range of pharmaceuticals and pharmaceutical preparations; contact lens disinfecting, cleaning, storing and rewetting solutions

Downloadable and recorded computer software for accessing information related to all aspects of health, personal care, nutrition, wellness, and the development and use of pharmaceuticals, medicaments and medical products of all kinds; optical lenses for vision correction; contact lenses; eyeglass lenses

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 27, 2026 EX3G
SOU TEAS EXTENSION RECEIVED
Mar 27, 2026 EEXT
SOU EXTENSION 3 FILED
Mar 26, 2026 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 7, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 7, 2025 EX2G
SOU TEAS EXTENSION RECEIVED
Oct 3, 2025 EEXT
SOU EXTENSION 2 FILED
Oct 2, 2025 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2025 EXRA
CORRECTED NOA E-MAILED
Oct 2, 2025 NOAC
CORRECTED NOA E-MAILED
Oct 2, 2025 NOAC
DIVISIONAL PROCESSING COMPLETE
Oct 2, 2025 DPCC
SOU EXTENSION 1 GRANTED
Oct 2, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 3, 2025 AITU
DIVISIONAL REQUEST RECEIVED
Apr 16, 2025 DRRR
SOU EXTENSION 1 FILED
Apr 16, 2025 EXT1
TEAS REQUEST TO DIVIDE RECEIVED
Apr 16, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Apr 16, 2025 EISU
SOU TEAS EXTENSION RECEIVED
Apr 16, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 22, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 18, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2023 NWOS
NEW APPLICATION ENTERED
Sep 18, 2023 NWAP